Priya Tiwari (@Priya1111) header
Priya Tiwari (@Priya1111) profile picture

Medical Oncologist

Gurugram Haryana India
Joined March 2009
Photo by Priya Tiwari (@Priya1111)Photo by Priya Tiwari (@Priya1111)Photo by Priya Tiwari (@Priya1111)Photo by Priya Tiwari (@Priya1111)Photo by Priya Tiwari (@Priya1111)Photo by Priya Tiwari (@Priya1111)Photo by Priya Tiwari (@Priya1111)
Priya Tiwari retweeted
#Vaping is not cool—it’s harmful, addictive and illegal in India. 🚭 Let’s empower our children & youth to make healthy choices and say NO to e-cigarettes and vapes. Protecting young minds means building a #tobacco & #nicotine #free #generation. #NashaMuktBharat #TFYC4
3
16
26
484
One more reason to take Delhi's smog seriously: WHO's cancer agency (IARC) classifies outdoor air pollution and particulate matter as Group 1 carcinogens, with sufficient evidence for lung cancer. On severe AQI days, limit outdoor exposure, esp. for kids. nitter.cf/ndtv/status/2122155077…
Delhi continues to battle poor air quality as thick smog blankets the city. Which age group of children faces the greatest risk from pollution exposure? Watch Dr Sanjeev Bagai speak to @snehamordani about the impact of toxic air on children's health and how parents can protect them. @ShivaniSinghRna
2
4
1
10
1,101
Priya Tiwari retweeted
Ooo, supportive care. Easy win for patients. Looks like swapping olanzapine out for mirtazapine significantly reduces nausea. Relevant to every oncologist. Randomized trial from India at #ESMO26. 120 chemo-naive patients starting highly emetogenic chemo, randomized 1:1. Both arms got fosaprepitant + palonosetron + dex. Fourth drug was mirtazapine 15 mg vs olanzapine 5 mg, days 1–4. Mirtazapine vs olanzapine:
Acute 78.5% vs 56.4%, p=0.01
Delayed 52.3% vs 25.5%, p=0.003
Overall 46.2% vs 21.8%, p=0.005 Major differences 120 patients? Minimal risk? I'm sold. The day after the paper comes out, I'll swap. @realbowtiedoc thoughts? @OncoAlert @TheGutOncLab @Onco_Nexus
8
32
4
121
10,153
Priya Tiwari retweeted
#ESMO26 starts tomorrow. Once again, I'm sharing the table I share before every major congress. ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) 💥 Recommended thresholds for clinically meaningful benefit. 👇
4
23
62
4,551
Priya Tiwari retweeted
In 100% agreement Exercise should be a prescribed New @JACCJournals @ACCinTouch scientific statement jacc.org/doi/10.1016/j.jacc.…
50
452
41
1,556
120,466
Priya Tiwari retweeted
தேவிக்கு ஓர் இசை அர்ப்பணம் நவராத்திரி கொண்டாடத்தின் முதல் நாளில் குங்கும அபிஷேகத்தில் தேவி லிங்க பைரவி. ஈஷா யோக மையதத்தில் உள்ள சூரிய குண்டம் மண்டபத்தில் இசை மற்றும் நடன நிகழ்ச்சி உற்சாகமாக நடைபெற்றது. அதன் சிறு தொகுப்பு உங்களுக்காக! #IshaNavratri #NavratriDay1
12
117
22
320
1,931
Priya Tiwari retweeted
ASCO’s decision to reduce the waiting period for members to access meeting content from 12 months to just 30 days is a significant step toward accelerating access to scientific knowledge. Thank you, @ASCO !
3
9
79
3,549
🚨 Can carboplatin work in HRR-mutated mCRPC? Our prospective phase II CIPHER trial evaluated single-agent carboplatin in men with metastatic castration-resistant prostate cancer harboring germline or somatic HRR alterations. 📊 39 patients treated • PSA50 response: 41.0% • Median rPFS: 4.53 months • ORR: 32.3% among radiographically assessable patients • Median duration of response: 6.93 months 🧬 Response varied by genotype: • BRCA2: PSA50 63% • BRCA1: 33% • ATM: 22% • PALB2: 100% (2/2) An interesting exploratory signal: Germline HRR alterations had higher PSA50 responses than somatic alterations: 62.5% vs 26.1%. Take-home: Carboplatin showed meaningful activity in molecularly selected HRR-altered mCRPC, particularly in BRCA-associated disease, and may offer a pragmatic option where access to PARP inhibitors is limited. 📄 CIPHER | ESMO Open 2026 @ESMO_Open @oncoalert @ASCO #ProstateCancer #mCRPC #PrecisionOncology #CIPHER
1
16
1
25
8,677
Behind Varanasi’s vibrant lanes lies Gulabi Meenakari—a centuries-old craft preserved with dedication by local artisans. Explore the stories and traditions that make India incredible. Credit: maroofculmen (IG) #IncredibleIndia #UttarPradesh #Varanasi #Art #Meenakari #Culture
57
6
243
35,188
Explore Sarnath, India's 45th #UNESCO World Heritage Site, where Lord #Buddha delivered his first sermon and the Wheel of Dharma was set in motion. Discover the Dhamek Stupa, commemorating the traditional site within the Deer Park where Lord Buddha delivered his first sermon; the Chaukhandi Stupa, commemorating his meeting with his first disciples; and the Dharmarajika Stupa, one of the earliest Buddhist stupas commissioned by Emperor Ashoka. Experience the enduring legacy of one of the world's most sacred Buddhist sites. #Sarnath #UNESCOWorldHeritage #BuddhistHeritage #VisitIndia #IncredibleIndia
1
117
6
524
34,753
How two young Indians are converting discarded shoes into slippers for school children in need ! At the GreenSole Foundation, founders Shriyans Bhandari and Ramesh Dhami have made it their mission to give discarded footwear a second life. Their initiative has impacted the lives of over eight lakh people across India. Last year alone, 1,30,589 pairs of slippers and 95,357 school bags were distributed to children. Most shoes we throw away are made from a complex mix of rubber, plastics, foam, leather, and textiles, making them extremely difficult to recycle. Globally, nearly 20 billion pairs of shoes are produced every year ending up in landfills. Next time you think of throwing away a pair of shoes, donate them & be part of the solution. #sustainability greensolefoundation.com
15
106
3
437
15,833
Priya Tiwari retweeted
Applications are now open for the International Collaboration for Research methods Development in Oncology (CReDO) Workshop—a six-day residential oncology research protocol development workshop. (1st–6th March 2027). Application deadline: 31st July 2026. I strongly encourage oncology residents, fellows and early-career faculty with an interest in clinical research to apply. Don't be deterred by the listed fee—most selected participants receive ~90% fee support through external grants. #CReDO @OncoDaily @cspramesh @OncBrothers @oncology_bg @SirohiBhawna
1
12
1
30
5,205
Priya Tiwari retweeted
🔥off the press🔥 Durvalumab with gemcitabine-based CTx in advanced BTC: primary results from the phase IIIb TOURMALINE study doi.org/10.1016/j.jhep.2026.… @JHepatology 👉Consistent efficacy & safety across 7 different chemo regimes @myESMO @EASLnews @ILCAnews @curecc
1
41
1
69
11,690
🆕editorial in press: PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block? @Al3ssandroRusso doi.org/10.1016/j.annonc.202…
1
12
27
3,696
Priya Tiwari retweeted
We have excellent webinar today on GU updates from ASCO 2026. It was well attended by over 145 oncologist . I thank all my faculty for taking time out from their busy schedules . I learned a lot from this discussion. I hope it was useful for all those who attended it . #OncoWisdom Thank you @sonpavde @gbanna74 @yekeduz_emre @DVAraujoMD @VanitaNoronha @Priya1111 @DrUddiGoswami @OncBrothers @oncodaily
3
11
1
27
3,157
Priya Tiwari retweeted
Outcomes of Y90-radioembolization as downstaging to liver transplantation HCC and tumoral portal vein thrombosis @HEP_Journal doi.org/10.1097/HEP.00000000… 👉25% sustained downstaging after TARE 👉15% eventually LTx with good outcome 🧐Downstaging is feasible in MVI pts @myESMO @ILCAnews @EASLnews
2
36
65
3,387
Priya Tiwari retweeted
🔥off the press🔥 Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Phase 3 RASolute 302 inMetastatic Pancreatic Cancer 👉mOS 13.2 vs 6.7 mo; HR:0.40 (p < 0.0001) 👏finally a significant benefit in PDAC, looking forward to 1st line studies @myESMO @ASCOPost
4
18
1
43
2,729
Priya Tiwari retweeted
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Lowand Mid-Rectal Cancers @JCO_ASCO doi.org/10.1200/JCO-25-01861 👏excellent review 👉Adopting a location-specific, patient-centered approach is key @myESMO @ASCO
24
55
2,863
Priya Tiwari retweeted
The European Society of Gynaecological Oncology consensus statements published in JAMA support opportunistic salpingectomy as a preventive measure against tubo-ovarian carcinoma, safe and feasible during pelvic or abdominal surgery. 🎥 Watch the video and learn more: ja.ma/4cjTkbP
1
15
3
65
12,888
DYK: The Indian government is rolling out a massive nationwide campaign to provide the HPV (Human Papillomavirus) vaccine for free, targeting cervical cancer—the second most common cancer among women in the country. Here is the breakdown of what this 90-day "mega drive" looks like: Key Details of the Drive Target Group: Specifically, girls aged 14 years. This age was chosen because the vaccine is most effective when administered before exposure to the virus, and the immune response is particularly robust in this group. The Vaccine: The government is using Gardasil 4 (a quadrivalent vaccine), which protects against the four most common strains of HPV (6, 11, 16, and 18). The Supply: 2.6 crore doses have been secured through a partnership with Gavi, the Vaccine Alliance, ensuring a steady supply for the next two years. Single-Dose Strategy: In line with updated WHO recommendations, India is opting for a single-shot schedule, which scientific evidence shows provides durable protection for girls in this age bracket. How to Get the Shot The rollout is expected to begin in the first week of March 2026. Where: Available free of cost at government health facilities, including Ayushman Arogya Mandirs (Primary Health Centres), Community Health Centres, and District Hospitals. Registration: Parents and guardians can book appointments through the U-WIN portal (similar to the Co-WIN system used during the pandemic). Voluntary: While highly encouraged, the vaccination is voluntary. This is a huge step toward the goal of eliminating cervical cancer in India, potentially saving tens of thousands of lives every year. @SumiSukanya carries my quotes in @IndiaToday indiatoday.in/health/story/f…
4
4
346